GB9801070D0 - HIV inhibition - Google Patents
HIV inhibitionInfo
- Publication number
- GB9801070D0 GB9801070D0 GBGB9801070.5A GB9801070A GB9801070D0 GB 9801070 D0 GB9801070 D0 GB 9801070D0 GB 9801070 A GB9801070 A GB 9801070A GB 9801070 D0 GB9801070 D0 GB 9801070D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- hiv inhibition
- receptor
- albumin
- lipid
- prevented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
HIV infection may be prevented by using a material that does not bind lipids but binds preferentially to a receptor selected from the gp60 receptor and albumin receptors, on target cells. Such materials include albumin fragments having no lipid-binding domain.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9801070.5A GB9801070D0 (en) | 1998-01-19 | 1998-01-19 | HIV inhibition |
AU21752/99A AU2175299A (en) | 1998-01-19 | 1999-01-19 | Hiv inhibition using ligand for gp60 receptor or albumin receptor on target cells |
PCT/GB1999/000174 WO1999036092A2 (en) | 1998-01-19 | 1999-01-19 | Hiv inhibition using ligand for gp60 receptor or albumin receptor on target cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9801070.5A GB9801070D0 (en) | 1998-01-19 | 1998-01-19 | HIV inhibition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9801070D0 true GB9801070D0 (en) | 1998-03-18 |
Family
ID=10825503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9801070.5A Ceased GB9801070D0 (en) | 1998-01-19 | 1998-01-19 | HIV inhibition |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2175299A (en) |
GB (1) | GB9801070D0 (en) |
WO (1) | WO1999036092A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9930160D0 (en) * | 1999-12-22 | 2000-02-09 | Biovector Solutions Limited | Drug delivery |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01217540A (en) * | 1988-02-25 | 1989-08-31 | Toshiba Corp | Document preparing device |
DE69326069T2 (en) * | 1992-07-20 | 2000-03-23 | Univ Durham | COMPOSITIONS THAT INHIBIT HIV REPLICATION |
CA2230479A1 (en) * | 1995-09-21 | 1997-03-27 | Andaris Limited | Transcytosis vehicles and enhancers for drug delivery |
-
1998
- 1998-01-19 GB GBGB9801070.5A patent/GB9801070D0/en not_active Ceased
-
1999
- 1999-01-19 AU AU21752/99A patent/AU2175299A/en not_active Abandoned
- 1999-01-19 WO PCT/GB1999/000174 patent/WO1999036092A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2175299A (en) | 1999-08-02 |
WO1999036092A3 (en) | 1999-10-28 |
WO1999036092A2 (en) | 1999-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20002800L (en) | Cyclosporin-containing microemulsion, for concentrate composition | |
HK1027585A1 (en) | Improved antiog composition for polyolefin packaging films and use thereof. | |
IL141452A0 (en) | Methods and compositions for modulating the interaction between the apj receptor and the hiv virus | |
AU6450298A (en) | Leukotriene antagonists useful for treating squamous cell carcinoma | |
TR200102041T2 (en) | 2-arylmino heterocycles substituted as progesterone receptor binding agents | |
DE69001295T2 (en) | COMPOSITIONS CONTROLLING IN THE FEEDER. | |
ZA200201789B (en) | Substituted pyrrolidin-2,3,4-trion-3-oxime drivatives useful as NMDA-receptor antagonists. | |
GB9801070D0 (en) | HIV inhibition | |
ID26857A (en) | E-2- (4-CHLORO-1,2-DIFENYL-BUT-I-ENIL) PHENOCHY) ETHANOL AND THE PHARMACY COMPOSITIONS | |
ITGE940069A0 (en) | DEVICE FORFORMING-TRANSFERRING OF PACKAGE FILES, IN PARTICULAR OF CIGARETTE PACKETS, OR THE SIMILAR. | |
DE69503143T2 (en) | AGAINST CRYOLITE-RESISTANT, FIRE-RESISTANT MATERIAL | |
ZA985101B (en) | Peptides and compounds that bind to the IL-5 receptor. | |
DE9409360U1 (en) | Envelope, mailing bag or the like | |
ES1032480Y (en) | DEVICE FOR THE DEPOSIT AND COLLECTION OF PACKAGES, DOCUMENTS AND SIMILAR. | |
RU98109987A (en) | MEANS FOR PROTECTION AGAINST GEOPATOGENIC EXPOSURE | |
EP0622377A3 (en) | Amphotropic virus receptor. | |
ES1032513Y (en) | PERFECTED BUCKET FOR GARBAGE. | |
RU98113788A (en) | COMPOUNDS HAVING PROPERTIES OF RELEASE HORMONE HORMONE | |
ES1027239Y (en) | PERFECTED BIN. | |
AU3343997A (en) | Plate, made from crystallizable thermoplastic, with a scratch-resistant coating | |
DE9405325U1 (en) | Folder, stapler or the like | |
ES1026570Y (en) | PERFECTED FIREPROOF BIN. | |
ITBO980110A0 (en) | UNIT FOR THE FORMATION OF STACKS OF ARTICLES. | |
DE29709011U1 (en) | Envelope, mailing bag or the like | |
DE9319600U1 (en) | Folder, folder, collector or the like. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |